drugset / Trial / NCT04477096
Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine
NaSequentialOpen-labelOther
Summary
The study is being conducted to evaluate drug interaction between HS-10234 and Emtricitabine after multiple dose in healthy subjects.
Timeline
- Start
- 2020-08-03
- Primary completion
- 2020-09-24
- Completion
- 2020-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10234 | Unknown | 25 mg | Oral |
| Subject | emtricitabine | Other / unclassified | 200 mg | Oral |
Indications
No indication recorded.